In addition, BEZ235 has been reported to inhibit cell viability and enhance the radiosensitivity of colorectal cancer (CRC) both in vitro and in vivo through the attenuation of radiation-inducing AKT/mTOR signaling activation and the inhibition of the DNA-DSB repair mechanism [28]. Here, AKT1 is linked to colorectal carcinoma.